Explore more publications!
Vatican Health Times
Got News to Share?

Vatican Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Health Times.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 3, 2025

World Class Health Partners with GAM to Select and Directly Contract with Top Quality Surgeons
December 3, 2025

World Class Health Partners with GAM to Select and Directly Contract with Top Quality Surgeons

Indeterminate GlobeNewswire
Immuron New U.S. Department of Defense Award & Clinical Trial Update
December 3, 2025

Immuron New U.S. Department of Defense Award & Clinical Trial Update

Indeterminate GlobeNewswire
Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date
December 3, 2025

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date

Indeterminate GlobeNewswire
MUVON Therapeutics Reports Positive Phase 2 Results for its First-in-Class Muscle Precursor Cell (MPC)-based Tissue-Engineered Therapy Showing Clinically Meaningful and Statistically Significant Benefits in Stress Urinary Incontinence
December 3, 2025

MUVON Therapeutics Reports Positive Phase 2 Results for its First-in-Class Muscle Precursor Cell (MPC)-based Tissue-Engineered Therapy Showing Clinically Meaningful and Statistically Significant Benefits in Stress Urinary Incontinence

Indeterminate GlobeNewswire
Future of Anticancer Drug Market 2025-2032 Emerging Oncology Therapies, Market Opportunities, and Global Competitive Strategies: AnalystView Market Insights
December 3, 2025

Future of Anticancer Drug Market 2025-2032 Emerging Oncology Therapies, Market Opportunities, and Global Competitive Strategies: AnalystView Market Insights

Indeterminate GlobeNewswire
Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer
December 3, 2025

Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer

Indeterminate GlobeNewswire
Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671
December 3, 2025

Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671

Indeterminate GlobeNewswire
Elevation Spine Center Expands Bend Clinic to Offer Easier Access to Advanced, Lasting Pain Relief
December 3, 2025

Elevation Spine Center Expands Bend Clinic to Offer Easier Access to Advanced, Lasting Pain Relief

Indeterminate GlobeNewswire
Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
December 3, 2025

Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions